A detailed history of National Bank Of Canada transactions in Astrazeneca PLC stock. As of the latest transaction made, National Bank Of Canada holds 158,329 shares of AZN stock, worth $10.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
158,329
Previous 158,329 -0.0%
Holding current value
$10.4 Million
Previous $12.3 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.67 - $87.62 $4.25 Million - $4.86 Million
55,473 Added 53.93%
158,329 $12.3 Million
Q2 2024

Aug 02, 2024

SELL
$66.81 - $80.83 $7.18 Million - $8.69 Million
-107,511 Reduced 51.11%
102,856 $8.02 Million
Q1 2024

May 13, 2024

SELL
$61.03 - $69.57 $18.4 Million - $21 Million
-301,829 Reduced 58.93%
210,367 $14.3 Million
Q4 2023

Feb 06, 2024

SELL
$61.89 - $69.28 $18 Million - $20.1 Million
-290,414 Reduced 36.18%
512,196 $34.5 Million
Q3 2023

Oct 10, 2023

SELL
$64.85 - $71.7 $671,586 - $742,525
-10,356 Reduced 1.27%
802,610 $54.4 Million
Q2 2023

Jul 26, 2023

BUY
$69.91 - $75.81 $5.43 Million - $5.89 Million
77,664 Added 10.56%
812,966 $58.2 Million
Q1 2023

Apr 12, 2023

BUY
$63.15 - $71.6 $32.6 Million - $37 Million
516,453 Added 235.99%
735,302 $51 Million
Q4 2022

Jan 24, 2023

BUY
$54.21 - $70.44 $107,715 - $139,964
1,987 Added 0.92%
218,849 $0
Q3 2022

Oct 13, 2022

SELL
$53.02 - $135.75 $313,136 - $801,739
-5,906 Reduced 2.65%
216,862 $11.8 Million
Q2 2022

Jul 28, 2022

SELL
$59.26 - $71.14 $18,903 - $22,693
-319 Reduced 0.14%
222,768 $14.7 Million
Q1 2022

May 05, 2022

SELL
$55.72 - $67.12 $6.12 Million - $7.37 Million
-109,820 Reduced 32.99%
223,087 $15.2 Million
Q4 2021

Jan 24, 2022

BUY
$54.02 - $63.83 $18 Million - $21.2 Million
332,907 New
332,907 $19.4 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.